SCHEMBL22015639

SCHEMBL22015639

COCCc1cc(-c2nc3ccccc3s2)ccc1OCCOCCOCCOCCO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.51
SMN1; SMN2 Q16637 10/20 0.51
KDM4E B2RXH2 8/20 0.51
TP53 P04637 7/20 0.51
NPC1 O15118 4/20 0.51
ALDH1A1 P00352 4/20 0.51
KMT2A Q03164 4/20 0.51
HPGD P15428 3/20 0.51
MEN1 O00255 3/20 0.51
BLM P54132 2/20 0.51
HCRTR1 O43613 1/20 0.51
MAPK1 P28482 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
HSD17B10 Q99714 1/20 0.51
RAB9A P51151 6/20 0.48
GLA P06280 2/20 0.48
PPARG P37231 2/20 0.48
GAA P10253 1/20 0.48
NCOA2 Q15596 1/20 0.48
NCOA1 Q15788 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22015765 0.85 HDAC1 (0.51) MAPTSMN1; SMN2KDM4ETP53NPC1
SCHEMBL22015994 0.84 MAPT (0.53) MAPTSMN1; SMN2KDM4ETP53NPC1
SCHEMBL22015456 0.84 KDM4E (0.46) MAPTSMN1; SMN2KDM4ETP53NPC1
SCHEMBL22015459 0.83 MAPT (0.51) MAPTSMN1; SMN2KDM4ETP53NPC1
SCHEMBL25713690 0.83 KDM4E (0.51) MAPTSMN1; SMN2KDM4ETP53NPC1
SCHEMBL22015996 0.82 SMN1; SMN2 (0.51) MAPTSMN1; SMN2KDM4ETP53NPC1
SCHEMBL22015466 0.82 APP (0.53) MAPTSMN1; SMN2KDM4ETP53NPC1
SCHEMBL22015638 0.82 PTGS1 (0.54) MAPTSMN1; SMN2KDM4ETP53NPC1
SCHEMBL22015453 0.82 MAPT (0.50) MAPTSMN1; SMN2KDM4ETP53NPC1
SCHEMBL20715410 0.82 SMN1; SMN2 (0.50) MAPTSMN1; SMN2KDM4ETP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017477-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS SPINOGENIX, INC. 2022-01-20 US disclosed
US-11117878-B2 Benzothiazole and related compounds SPINOGENIX, INC. (US) 2021-09-14 US disclosed
US-20200157068-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS SPINOGENIX, INC. 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017477-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS BACE1, APP, BACE2 MAPT 5/4885SMN1; SMN2 25/4885KDM4E 3807/4885
US-11117878-B2 Benzothiazole and related compounds BACE1, APP, BACE2 MAPT 5/4885SMN1; SMN2 25/4885KDM4E 3807/4885
US-20200157068-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS BACE1, APP, BACE2 MAPT 5/4885SMN1; SMN2 25/4885KDM4E 3807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.